Sygdomsmekanismer og nye behandlingsmetoder ved migræne
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Standard
Sygdomsmekanismer og nye behandlingsmetoder ved migræne. / Hansen, Jakob Møller; Ashina, Messoud.
I: Ugeskrift for Laeger, Bind 178, V07160507, 2016.Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Sygdomsmekanismer og nye behandlingsmetoder ved migræne
AU - Hansen, Jakob Møller
AU - Ashina, Messoud
PY - 2016
Y1 - 2016
N2 - Migraine is the most prevalent disabling neurological disorder. The management of patients with migraine has been hampered by lack of effective and well-tolerated acute and preventive therapies. Based on improved insights into the basic mechanisms of migraine, new and targeted treatments are currently undergoing large-scale testing. Among the most promising agents for migraine prevention are humanized antibodies against calcitonin gene-related peptide (CGRP) or the CGRP receptor. If proven effective, these new treatments may emerge to improve the lives of millions of individuals worldwide disabled by migraine.
AB - Migraine is the most prevalent disabling neurological disorder. The management of patients with migraine has been hampered by lack of effective and well-tolerated acute and preventive therapies. Based on improved insights into the basic mechanisms of migraine, new and targeted treatments are currently undergoing large-scale testing. Among the most promising agents for migraine prevention are humanized antibodies against calcitonin gene-related peptide (CGRP) or the CGRP receptor. If proven effective, these new treatments may emerge to improve the lives of millions of individuals worldwide disabled by migraine.
KW - Journal Article
KW - English Abstract
M3 - Tidsskriftartikel
C2 - 28041540
VL - 178
JO - Ugeskrift for Laeger
JF - Ugeskrift for Laeger
SN - 0041-5782
M1 - V07160507
ER -
ID: 181027284